1,165 results on '"Berkowitz, Ross S."'
Search Results
2. The impact of the distance traveled between residence and gestational trophoblastic neoplasia reference center and clinical outcomes in Brazilian women
3. Presentation, medical complications and development of gestational trophoblastic neoplasia of hydatidiform mole after intracytoplasmic sperm injection as compared to hydatidiform mole after spontaneous conception - a retrospective cohort study and literature review
4. EMACO for treatment of gestational trophoblastic neoplasia: A multinational multicenter study
5. Gestational trophoblastic disease
6. Contributors
7. Immunotherapy in the treatment of chemoresistant gestational trophoblastic neoplasia - systematic review with a presentation of the first 4 Brazilian cases
8. ATR and CDK4/6 inhibition target the growth of methotrexate-resistant choriocarcinoma
9. Loss of Selenoprotein Iodothyronine Deiodinase 3 Expression Correlates with Progression of Complete Hydatidiform Mole to Gestational Trophoblastic Neoplasia
10. Predictors for single-agent resistance in FIGO score 5 or 6 gestational trophoblastic neoplasia: a multicentre, retrospective, cohort study
11. Disease Distribution at Presentation Impacts Benefit of IP Chemotherapy Among Patients with Advanced-Stage Ovarian Cancer
12. Outcomes for relapsed versus resistant low risk gestational trophoblastic neoplasia following single-agent chemotherapy
13. Diagnosis and Management of Gestational Trophoblastic Neoplasia
14. Gestational trophoblastic neoplasia lethality among Brazilian women: A retrospective national cohort study
15. EMA vs EMACO in the treatment of gestational trophoblastic neoplasia
16. Effectiveness and toxicity of second-line actinomycin D in patients with methotrexate-resistant postmolar low-risk gestational trophoblastic neoplasia
17. Comparison of treatment for low-risk GTN with standard 8-day MTX/FA regimen versus modified MTX/FA regimen without chemotherapy on the weekend
18. MicroRNA-200 family governs ovarian inclusion cyst formation and mode of ovarian cancer spread
19. Liquid biopsy of HPV DNA in cervical cancer
20. Can carboplatin or etoposide replace actinomycin-d for second-line treatment of methotrexate resistant low-risk gestational trophoblastic neoplasia?
21. Infection, thrombosis, and oncologic outcome after interval debulking surgery: Does perioperative blood transfusion matter?
22. Correction: ATR and CDK4/6 inhibition target the growth of methotrexate-resistant choriocarcinoma
23. Contributors
24. Gestational Trophoblastic Disease
25. Moving beyond “complete surgical resection” and “optimal”: Is low-volume residual disease another option for primary debulking surgery?
26. Meigs to modern times: The evolution of debulking surgery in advanced ovarian cancer
27. Does a human chorionic gonadotropin level of over 20,000 IU/L four weeks after uterine evacuation for complete hydatidiform mole constitute an indication for chemotherapy for gestational trophoblastic neoplasia?
28. Is chemotherapy always necessary for patients with nonmetastatic gestational trophoblastic neoplasia with histopathological diagnosis of choriocarcinoma?
29. Effectiveness and toxicity of first-line methotrexate chemotherapy in low-risk postmolar gestational trophoblastic neoplasia: The New England Trophoblastic Disease Center experience
30. Characterization of miR-200 family members as blood biomarkers for human and laying hen ovarian cancer
31. Does hormonal contraception during molar pregnancy follow-up influence the risk and clinical aggressiveness of gestational trophoblastic neoplasia after controlling for risk factors?
32. First-Trimester Ultrasound in Gestational Trophoblastic Disease
33. Liquid biopsy of PIK3CA mutations in cervical cancer in Hong Kong Chinese women
34. Multiple pregnancies with complete mole and coexisting normal fetus in North and South America: A retrospective multicenter cohort and literature review
35. Differentiated exophytic vulvar intraepithelial lesions are genetically distinct from keratinizing squamous cell carcinomas and contain mutations in PIK3CA
36. Placental site trophoblastic tumors and epithelioid trophoblastic tumors: Biology, natural history, and treatment modalities
37. Video Hysteroscopy in the Diagnosis of Molar Pregnancy in two Challenging Situations: Complete Mole with Normal hCG and Partial Mole with Early Gestational Age
38. Considering Changes in the Recommended Human Chorionic Gonadotropin Monitoring After Molar Evacuation
39. Is chemotherapy necessary for patients with molar pregnancy and human chorionic gonadotropin serum levels raised but falling at 6 months after uterine evacuation?
40. Cyclin A1 expression and paclitaxel resistance in human ovarian cancer cells
41. Diagnosis and Management of Gestational Trophoblastic Neoplasia
42. Supplementary Table 5 from Prediction of DNA Repair Inhibitor Response in Short-Term Patient-Derived Ovarian Cancer Organoids
43. Supplementary Table 1 from Prediction of DNA Repair Inhibitor Response in Short-Term Patient-Derived Ovarian Cancer Organoids
44. Supplementary Table 2 from Prediction of DNA Repair Inhibitor Response in Short-Term Patient-Derived Ovarian Cancer Organoids
45. Supplementary Table 3 from Prediction of DNA Repair Inhibitor Response in Short-Term Patient-Derived Ovarian Cancer Organoids
46. Data from Prediction of DNA Repair Inhibitor Response in Short-Term Patient-Derived Ovarian Cancer Organoids
47. Supplementary Text and Figures from Prediction of DNA Repair Inhibitor Response in Short-Term Patient-Derived Ovarian Cancer Organoids
48. Supplementary Table 4 from Prediction of DNA Repair Inhibitor Response in Short-Term Patient-Derived Ovarian Cancer Organoids
49. Supplementary Gene List from Expression Profiling of Mucinous Tumors of the Ovary Identifies Genes of Clinicopathologic Importance
50. Data from Enhanced Efficacy of Simultaneous PD-1 and PD-L1 Immune Checkpoint Blockade in High-Grade Serous Ovarian Cancer
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.